Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Adalimumab (Atc Code According To Who: L04Ab04)
Deadline - Nov 30, 2026
GT reference number - 101787935
Product classification - Medical equipments, pharmaceuticals and personal care products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 101787935
Document Type - Tender Notices
Description - notice_title: Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Adalimumab (Atc Code According To Who: L04Ab04)local title:: Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Adalimumab (ATC-Code nach WHO: L04AB04)local description: : Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Adalimumab (ATC-Code nach WHO: L04AB04)
Gt Ref Id - 101787935
Deadline - Nov 30, 2026
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database